Prevention of ventricular fibrillation requires central β-adrenoceptor blockade in rabbits

Abstract

Objective. To study whether and how a lipophilic and a hydrophilic β-adrenoceptor antagonist affects ventricular fibrillation (VF) after coronary artery occlusion in a rabbit model with high sympathetic and low cardiac vagal activation. Design. Rabbits were treated for 3 weeks (series 1) or 2 hours (series 2) with metoprolol, atenolol or control vehicle. Finally the animals in series 1 were exposed to coronary artery occlusion. Heart rate response to cholinergic blockade was studied in series 2. Results. The incidence of postocclusion VF in metoprolol animals was lower (p<0.05) than that in atenolol or control animals. The two β-blockers caused similar reductions of heart rate, arterial pressure and myocardial ischemia. However, metoprolol animals had more respiratory sinus arrhythmia higher baroreflex sensitivity and more pronounced tachycardic response to cholinergic blockade than atenolol animals. Conclusion. Metoprolol reduced the incidence of VF by a better maintained discharge than atenolol in efferent cardiac vagal nerves, possibly due to inhibition of central nervous β₁ adrenoceptors modulating vagal nervous outflow.

• Cardiac vagal activity
• metoprolol
• atenolol
• ventricular fibrillation